Global Endometriosis Drugs Market Professional Survey Report 2019

Publisher Name :
Date: 09-Sep-2019
No. of pages: 116
Inquire Before Buying

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.

The global Endometriosis Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Endometriosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Drugs market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis Drugs in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Endometriosis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- AbbVie

- Astellas Pharma

- AstraZeneca

- Debiopharm Group

- Evotec AG

- Kissei Pharmaceutical

- Neurocrine Biosciences

- ObsEva

- Pfizer

- Repros Therapeutics

- Roivant Sciences GmbH

- Takeda Pharmaceutical Company Limited

- ValiRx

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Hormonal Therapy

- Add-back Medication

- Progestogens

- Chinese Herbs

Segment by Application

- Hospitals

- Clinics

- Research Institutes

Global Endometriosis Drugs Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Endometriosis Drugs
1.1 Definition of Endometriosis Drugs
1.2 Endometriosis Drugs Segment by Type
1.2.1 Global Endometriosis Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Endometriosis Drugs Segment by Applications
1.3.1 Global Endometriosis Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Global Endometriosis Drugs Overall Market
1.4.1 Global Endometriosis Drugs Revenue (2014-2025)
1.4.2 Global Endometriosis Drugs Production (2014-2025)
1.4.3 North America Endometriosis Drugs Status and Prospect (2014-2025)
1.4.4 Europe Endometriosis Drugs Status and Prospect (2014-2025)
1.4.5 China Endometriosis Drugs Status and Prospect (2014-2025)
1.4.6 Japan Endometriosis Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Endometriosis Drugs Status and Prospect (2014-2025)
1.4.8 India Endometriosis Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Endometriosis Drugs
2.3 Manufacturing Process Analysis of Endometriosis Drugs
2.4 Industry Chain Structure of Endometriosis Drugs
3 Development and Manufacturing Plants Analysis of Endometriosis Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Endometriosis Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Endometriosis Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Endometriosis Drugs Production and Capacity Analysis
4.2 Endometriosis Drugs Revenue Analysis
4.3 Endometriosis Drugs Price Analysis
4.4 Market Concentration Degree
5 Endometriosis Drugs Regional Market Analysis
5.1 Endometriosis Drugs Production by Regions
5.1.1 Global Endometriosis Drugs Production by Regions
5.1.2 Global Endometriosis Drugs Revenue by Regions
5.2 Endometriosis Drugs Consumption by Regions
5.3 North America Endometriosis Drugs Market Analysis
5.3.1 North America Endometriosis Drugs Production
5.3.2 North America Endometriosis Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Endometriosis Drugs Import and Export
5.4 Europe Endometriosis Drugs Market Analysis
5.4.1 Europe Endometriosis Drugs Production
5.4.2 Europe Endometriosis Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Endometriosis Drugs Import and Export
5.5 China Endometriosis Drugs Market Analysis
5.5.1 China Endometriosis Drugs Production
5.5.2 China Endometriosis Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Endometriosis Drugs Import and Export
5.6 Japan Endometriosis Drugs Market Analysis
5.6.1 Japan Endometriosis Drugs Production
5.6.2 Japan Endometriosis Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Endometriosis Drugs Import and Export
5.7 Southeast Asia Endometriosis Drugs Market Analysis
5.7.1 Southeast Asia Endometriosis Drugs Production
5.7.2 Southeast Asia Endometriosis Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Endometriosis Drugs Import and Export
5.8 India Endometriosis Drugs Market Analysis
5.8.1 India Endometriosis Drugs Production
5.8.2 India Endometriosis Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Endometriosis Drugs Import and Export
6 Endometriosis Drugs Segment Market Analysis (by Type)
6.1 Global Endometriosis Drugs Production by Type
6.2 Global Endometriosis Drugs Revenue by Type
6.3 Endometriosis Drugs Price by Type
7 Endometriosis Drugs Segment Market Analysis (by Application)
7.1 Global Endometriosis Drugs Consumption by Application
7.2 Global Endometriosis Drugs Consumption Market Share by Application (2014-2019)
8 Endometriosis Drugs Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Endometriosis Drugs Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Astellas Pharma
8.2.1 Astellas Pharma Endometriosis Drugs Production Sites and Area Served
8.2.2 Astellas Pharma Product Introduction, Application and Specification
8.2.3 Astellas Pharma Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Endometriosis Drugs Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Debiopharm Group
8.4.1 Debiopharm Group Endometriosis Drugs Production Sites and Area Served
8.4.2 Debiopharm Group Product Introduction, Application and Specification
8.4.3 Debiopharm Group Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Evotec AG
8.5.1 Evotec AG Endometriosis Drugs Production Sites and Area Served
8.5.2 Evotec AG Product Introduction, Application and Specification
8.5.3 Evotec AG Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Kissei Pharmaceutical
8.6.1 Kissei Pharmaceutical Endometriosis Drugs Production Sites and Area Served
8.6.2 Kissei Pharmaceutical Product Introduction, Application and Specification
8.6.3 Kissei Pharmaceutical Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Neurocrine Biosciences
8.7.1 Neurocrine Biosciences Endometriosis Drugs Production Sites and Area Served
8.7.2 Neurocrine Biosciences Product Introduction, Application and Specification
8.7.3 Neurocrine Biosciences Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 ObsEva
8.8.1 ObsEva Endometriosis Drugs Production Sites and Area Served
8.8.2 ObsEva Product Introduction, Application and Specification
8.8.3 ObsEva Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer
8.9.1 Pfizer Endometriosis Drugs Production Sites and Area Served
8.9.2 Pfizer Product Introduction, Application and Specification
8.9.3 Pfizer Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Repros Therapeutics
8.10.1 Repros Therapeutics Endometriosis Drugs Production Sites and Area Served
8.10.2 Repros Therapeutics Product Introduction, Application and Specification
8.10.3 Repros Therapeutics Endometriosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Roivant Sciences GmbH
8.12 Takeda Pharmaceutical Company Limited
8.13 ValiRx
9 Development Trend of Analysis of Endometriosis Drugs Market
9.1 Global Endometriosis Drugs Market Trend Analysis
9.1.1 Global Endometriosis Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Endometriosis Drugs Regional Market Trend
9.2.1 North America Endometriosis Drugs Forecast 2019-2025
9.2.2 Europe Endometriosis Drugs Forecast 2019-2025
9.2.3 China Endometriosis Drugs Forecast 2019-2025
9.2.4 Japan Endometriosis Drugs Forecast 2019-2025
9.2.5 Southeast Asia Endometriosis Drugs Forecast 2019-2025
9.2.6 India Endometriosis Drugs Forecast 2019-2025
9.3 Endometriosis Drugs Market Trend (Product Type)
9.4 Endometriosis Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Endometriosis Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Endometriosis Drugs
Table Global Endometriosis Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Endometriosis Drugs Production Market Share by Types in 2018
Figure Hormonal Therapy Product Picture
Figure Add-back Medication Product Picture
Figure Progestogens Product Picture
Figure Chinese Herbs Product Picture
Table Global Endometriosis Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Endometriosis Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Research Institutes
Figure Global Endometriosis Drugs Revenue (Million USD) (2014-2025)
Figure Global Endometriosis Drugs Production (K Units) (2014-2025)
Figure North America Endometriosis Drugs Market Size (Million USD) (2014-2025)
Figure Europe Endometriosis Drugs Market Size (Million USD) (2014-2025)
Figure China Endometriosis Drugs Market Size (Million USD) (2014-2025)
Figure Japan Endometriosis Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Endometriosis Drugs Market Size (Million USD) (2014-2025)
Figure India Endometriosis Drugs Market Size (Million USD) (2014-2025)
Table Endometriosis Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Endometriosis Drugs in 2018
Figure Manufacturing Process Analysis of Endometriosis Drugs
Figure Industry Chain Structure of Endometriosis Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Endometriosis Drugs Manufacturing Plants Distribution
Table Endometriosis Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Endometriosis Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Endometriosis Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Endometriosis Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Endometriosis Drugs Production Share by Manufacturers in 2018
Table Endometriosis Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Endometriosis Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Endometriosis Drugs Revenue Share by Manufacturers in 2018
Table Endometriosis Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Endometriosis Drugs Production by Regions 2014-2019 (K Units)
Table Global Endometriosis Drugs Production Market Share by Regions 2014-2019
Figure Global Endometriosis Drugs Production Market Share by Regions in 2018
Table Global Endometriosis Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Endometriosis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Endometriosis Drugs Revenue Market Share by Regions in 2018
Table Global Endometriosis Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Endometriosis Drugs Consumption Market Share by Regions 2014-2019
Figure North America Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure Europe Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure China Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure Japan Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure India Endometriosis Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Endometriosis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Endometriosis Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Endometriosis Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Endometriosis Drugs Market Share by Application (2014-2019)
Table AbbVie Endometriosis Drugs Production Sites and Area Served
Table AbbVie Endometriosis Drugs Product Introduction, Application and Specification
Table AbbVie Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Endometriosis Drugs Production Growth Rate (2014-2019)
Table AbbVie Endometriosis Drugs Production Market Share (2014-2019)
Figure AbbVie Endometriosis Drugs Revenue Market Share (2014-2019)
Table AbbVie Endometriosis Drugs Main Business and Markets Served
Table Astellas Pharma Endometriosis Drugs Production Sites and Area Served
Table Astellas Pharma Endometriosis Drugs Product Introduction, Application and Specification
Table Astellas Pharma Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Endometriosis Drugs Production Growth Rate (2014-2019)
Table Astellas Pharma Endometriosis Drugs Production Market Share (2014-2019)
Figure Astellas Pharma Endometriosis Drugs Revenue Market Share (2014-2019)
Table Astellas Pharma Endometriosis Drugs Main Business and Markets Served
Table AstraZeneca Endometriosis Drugs Production Sites and Area Served
Table AstraZeneca Endometriosis Drugs Product Introduction, Application and Specification
Table AstraZeneca Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Endometriosis Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Endometriosis Drugs Production Market Share (2014-2019)
Figure AstraZeneca Endometriosis Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Endometriosis Drugs Main Business and Markets Served
Table Debiopharm Group Endometriosis Drugs Production Sites and Area Served
Table Debiopharm Group Endometriosis Drugs Product Introduction, Application and Specification
Table Debiopharm Group Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Debiopharm Group Endometriosis Drugs Production Growth Rate (2014-2019)
Table Debiopharm Group Endometriosis Drugs Production Market Share (2014-2019)
Figure Debiopharm Group Endometriosis Drugs Revenue Market Share (2014-2019)
Table Debiopharm Group Endometriosis Drugs Main Business and Markets Served
Table Evotec AG Endometriosis Drugs Production Sites and Area Served
Table Evotec AG Endometriosis Drugs Product Introduction, Application and Specification
Table Evotec AG Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Evotec AG Endometriosis Drugs Production Growth Rate (2014-2019)
Table Evotec AG Endometriosis Drugs Production Market Share (2014-2019)
Figure Evotec AG Endometriosis Drugs Revenue Market Share (2014-2019)
Table Evotec AG Endometriosis Drugs Main Business and Markets Served
Table Kissei Pharmaceutical Endometriosis Drugs Production Sites and Area Served
Table Kissei Pharmaceutical Endometriosis Drugs Product Introduction, Application and Specification
Table Kissei Pharmaceutical Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kissei Pharmaceutical Endometriosis Drugs Production Growth Rate (2014-2019)
Table Kissei Pharmaceutical Endometriosis Drugs Production Market Share (2014-2019)
Figure Kissei Pharmaceutical Endometriosis Drugs Revenue Market Share (2014-2019)
Table Kissei Pharmaceutical Endometriosis Drugs Main Business and Markets Served
Table Neurocrine Biosciences Endometriosis Drugs Production Sites and Area Served
Table Neurocrine Biosciences Endometriosis Drugs Product Introduction, Application and Specification
Table Neurocrine Biosciences Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Neurocrine Biosciences Endometriosis Drugs Production Growth Rate (2014-2019)
Table Neurocrine Biosciences Endometriosis Drugs Production Market Share (2014-2019)
Figure Neurocrine Biosciences Endometriosis Drugs Revenue Market Share (2014-2019)
Table Neurocrine Biosciences Endometriosis Drugs Main Business and Markets Served
Table ObsEva Endometriosis Drugs Production Sites and Area Served
Table ObsEva Endometriosis Drugs Product Introduction, Application and Specification
Table ObsEva Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ObsEva Endometriosis Drugs Production Growth Rate (2014-2019)
Table ObsEva Endometriosis Drugs Production Market Share (2014-2019)
Figure ObsEva Endometriosis Drugs Revenue Market Share (2014-2019)
Table ObsEva Endometriosis Drugs Main Business and Markets Served
Table Pfizer Endometriosis Drugs Production Sites and Area Served
Table Pfizer Endometriosis Drugs Product Introduction, Application and Specification
Table Pfizer Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Endometriosis Drugs Production Growth Rate (2014-2019)
Table Pfizer Endometriosis Drugs Production Market Share (2014-2019)
Figure Pfizer Endometriosis Drugs Revenue Market Share (2014-2019)
Table Pfizer Endometriosis Drugs Main Business and Markets Served
Table Repros Therapeutics Endometriosis Drugs Production Sites and Area Served
Table Repros Therapeutics Endometriosis Drugs Product Introduction, Application and Specification
Table Repros Therapeutics Endometriosis Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Repros Therapeutics Endometriosis Drugs Production Growth Rate (2014-2019)
Table Repros Therapeutics Endometriosis Drugs Production Market Share (2014-2019)
Figure Repros Therapeutics Endometriosis Drugs Revenue Market Share (2014-2019)
Table Repros Therapeutics Endometriosis Drugs Main Business and Markets Served
Table Roivant Sciences GmbH Endometriosis Drugs Production Sites and Area Served
Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Production Sites and Area Served
Table ValiRx Endometriosis Drugs Production Sites and Area Served
Figure Global Endometriosis Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Endometriosis Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Endometriosis Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Endometriosis Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Endometriosis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Endometriosis Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Endometriosis Drugs by Application (2019-2025)
Table Endometriosis Drugs Distributors List
Table Endometriosis Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs